The binding of PD-L1, a membrane protein primarily expressed on tumor cells, to its membrane-bound receptor PD-1, which is mainly expressed on activated T lymphocytes and other immune cells, is a major and well-known immune checkpoint pathway regulating the interaction between the immune system and cancer cells in the tumor microenvironment [14]. Here, PDCD1 is linked to neoplasm.